Determining chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) incidence is challenging for two reasons: cancer registries tend to underreport CLL cases and its diagnostic criteria changed markedly in 2008. No studies have reported incidence rates dealing with both difficulties, and thus CLL/SLL burden in Europe is currently uncertain. Herein, we present accurate CLL/SLL incidence in a Spanish region during 1998–2013, using the population-based Girona Cancer Registry (GCR). We detected an 18.2% under-reporting of CLL/SLL cases when combining records from the GCR and additional information sources (i.e., records of flow cytometry laboratories, hospital registries and hematologists’ databases). In addition, age-adjusted rates (using the 2013 European population) changed from 7.57 (95% CI 6.87; 8.30) in 1998–2008 to 6.35 (95% CI 5.51; 7.30) in 2009–2013. Overall, completeness of CLL/SLL data requires accurate diagnosis and reporting of cases. Revision of cancer registry operations to include CLL/SLL-specific surveillance is likely to ensure that the monitoring of this malignancy is entirely accurate.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Sant M, Allemani C, Tereanu C et al (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734. https://doi.org/10.1182/blood-2010-05-282632
Turesson I, Linet MS, Bjorkholm M et al (2007) Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003. Int J cancer 121:2260–2266. https://doi.org/10.1002/ijc.22912
Zent CS, Kyasa MJ, Evans R, Schichman SA (2001) Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 92:1325–1330
Ruchlemer R, Zatlawi M, Fishler Y et al (2014) Cancer registries often underestimate the true incidence of CLL. Blood 124:5646
Call TG, Norman AD, Hanson CA et al (2014) Incidence of chronic lymphocytic leukemia and high count monoclonal B-cell lymphocytosis using the 2008 guidelines. Cancer 1:2000–2005. https://doi.org/10.1002/cncr.28690
Molica S, Giannarelli D, Mirabelli R et al (2014) Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines. Expert Rev Hematol 7:691–695. https://doi.org/10.1586/17474086.2014.954542
Healey R, Patel JL, de Koning L, Naugler C (2015) Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada. Leuk Res 39:429–434. https://doi.org/10.1016/j.leukres.2015.01.015
Seftel MD, Demers AA, Banerji V et al (2009) High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort. Leuk Res 33:1463–1468. https://doi.org/10.1016/j.leukres.2009.06.013
Brenner H, Gondos A, Pulte D (2008) Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 111:4916–4921. https://doi.org/10.1182/blood-2007-12-129379
da Cunha-Bang C, Geisler CH, Enggaard L et al (2016) The Danish National Chronic Lymphocytic Leukemia Registry. Clin Epidemiol 8:561–565. https://doi.org/10.2147/CLEP.S99486
Strati P, Shanafelt TD (2015) Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood 126:454–462. https://doi.org/10.1182/blood-2015-02-585059
Shanafelt TD, Kay NE, Rabe KG et al (2009) Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 27:3959–3963. https://doi.org/10.1200/JCO.2008.21.2704
Teras LR, DeSantis CE, Cerhan JR et al (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66:443–459. https://doi.org/10.3322/caac.21357
van den Broek EC, Kater AP, van de Schans SAM et al (2012) Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989–2008. Eur J Cancer 48:889–895. https://doi.org/10.1016/j.ejca.2011.06.053
Lenartova A, Johannesen TB, Tjønnfjord GE (2016) National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population-based data. Cancer Med 5:3588–3595. https://doi.org/10.1002/cam4.849
This work was supported by a grant from the Spanish Ministry of Health (FIS PI15/00966) and by CIBERESP (PhD contract to MS).
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Solans, M., Osca-Gelis, G., Comas, R. et al. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain. Cancer Causes Control 29, 379–382 (2018). https://doi.org/10.1007/s10552-018-1004-5
- Chronic lymphocytic leukemia
- 2008 Guidelines
- Cancer registry